Collective Health

Business/Productivity Software · San Francisco, CA · Founded 2013 · Privately Held (backing)

Developer of a cloud-based self-insurance platform designed to evolve how health benefits work. Collective Health is based in San Francisco, CA and was founded in 2013. It is valued at about $326 million as of Oct 2026, set by secondary market price, unchanged since its Series F in May 2021. It has raised $713 million across 1 recorded round; the latest was a $280 million Series F in May 2021.

PMV mark · valuation
$326.0M
Oct 2026
Secondary market · $/share
$0
Total raised
$713.3M
Last round
Later Stage VC (Series F)
May 2021

Collective Health key facts

as of Oct 2026
  • Developer of a cloud-based self-insurance platform designed to evolve how health benefits work.
  • Collective Health is valued at approximately $326.0M (~$0/share on the secondary market) as of Oct 2026, per PrivateMarketView’s mark.
  • It has raised $713.3M across 1 recorded rounds; the latest was Later Stage VC (Series F) ($280.0M) in May 2021.
  • Notable investors include Mubadala Investment Company, Gaingels, GV, Founders Fund, Calm Ventures — 50 tracked in total.
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$326.0M~$0 per share · secondary market

Unchanged since its Series F, May 2021 ($326.1M post-money).

set by secondary market priceas of Oct 2026question about this number?
Free account
More of Collective Health with a free account
  • ·The complete investor list: 50 names
  • ·Watch Collective Health: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Secondary market

monthly marks · 46 months · Jan 2023 – Oct 2026
Current
▮
High
▮
Low
▮
▮▮
Jan 2023marks: indicative $/share, month-end · as of Oct 15, 2026Oct 2026
Monthly marks are a Pro feature — the shape is real, the numbers are waiting.Unlock 46 monthly marks

Membership and data by Private Market View

Collective Health funding rounds

1 rounds
May 2021Later Stage VC (Series F)$280.0M▮

Collective Health valuation

Collective Health is valued at approximately $326 million as of Oct 2026. The figure is set by secondary market price. The secondary market quotes about $0 per share. The reference point is its Series F in May 2021, at a $326 million post-money valuation; the current figure is unchanged since.

Collective Health ranks 92nd by valuation and 59th by capital raised among the private companies PrivateMarketView tracks.

How much has Collective Health raised?

Collective Health has raised $713 million in total; 1 of its rounds is on record. The largest on record was a $280 million Series F in May 2021.

Collective Health secondary market activity

A monthly secondary-market price series for Collective Health runs from Jan 2023 to Oct 2026 (46 months).

Collective Health investors

50 investors are on record for Collective Health, including Mubadala Investment Company, Gaingels, GV and Founders Fund. By type, the record holds 21 venture capital firms and 2 hedge funds. The Series F in May 2021 drew 27 investors.

Who runs Collective Health

1 person is listed on the Collective Health team: 1 board member. 1 of them have a verified direct contact on file.

Comparable companies

Comparable business/productivity software names by valuation on PrivateMarketView: MarqVision ($319 million), Liquid AI ($317 million) and Lightning AI ($315 million).

About Collective Health

Developer of a cloud-based self-insurance platform designed to evolve how health benefits work. The company's platform offers integrated administration of all health plans through a single portal, which gives clear guidance, live concierge aid, and digital tools to find and manage care, enabling organizations to connect with medical, pharmacy, dental, and vision plans.

Industry
Business/Productivity Software
Sector
Health Care
HQ
San Francisco, CA, United States
Founded
2013
Employees
709
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.